Skip to Main Content

Paper Details

Rationale and design of the regimen education and messaging in diabetes (REMinD) trial.
Contemp Clin Trials
8
2019
Author NameAffiliation
Joseph KannryIcahn School of Medicine at Mount Sinai
Alastair J J WoodVanderbilt University School of Medicine
  • 1 - 2

Datasets

Release 1.2